Correlation Between Viridian Therapeutics and Edesa Biotech
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Edesa Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Edesa Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Edesa Biotech, you can compare the effects of market volatilities on Viridian Therapeutics and Edesa Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Edesa Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Edesa Biotech.
Diversification Opportunities for Viridian Therapeutics and Edesa Biotech
-0.29 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Viridian and Edesa is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Edesa Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edesa Biotech and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Edesa Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edesa Biotech has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Edesa Biotech go up and down completely randomly.
Pair Corralation between Viridian Therapeutics and Edesa Biotech
Given the investment horizon of 90 days Viridian Therapeutics is expected to generate 1.04 times more return on investment than Edesa Biotech. However, Viridian Therapeutics is 1.04 times more volatile than Edesa Biotech. It trades about 0.04 of its potential returns per unit of risk. Edesa Biotech is currently generating about -0.02 per unit of risk. If you would invest 1,722 in Viridian Therapeutics on August 27, 2024 and sell it today you would earn a total of 298.00 from holding Viridian Therapeutics or generate 17.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viridian Therapeutics vs. Edesa Biotech
Performance |
| Timeline |
| Viridian Therapeutics |
| Edesa Biotech |
Viridian Therapeutics and Edesa Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viridian Therapeutics and Edesa Biotech
The main advantage of trading using opposite Viridian Therapeutics and Edesa Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Edesa Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edesa Biotech will offset losses from the drop in Edesa Biotech's long position.| Viridian Therapeutics vs. Eliem Therapeutics | Viridian Therapeutics vs. HCW Biologics | Viridian Therapeutics vs. Scpharmaceuticals | Viridian Therapeutics vs. Milestone Pharmaceuticals |
| Edesa Biotech vs. Eliem Therapeutics | Edesa Biotech vs. HCW Biologics | Edesa Biotech vs. Scpharmaceuticals | Edesa Biotech vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |